Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial.
Quenby S, Booth K, Hiller L, Coomarasamy A, de Jong PG, Hamulyák EN, Scheres LJ, van Haaps TF, Ewington L, Tewary S, Goddijn M, Middeldorp S; ALIFE2 Block Writing Committee; ALIFE2 Investigators. Quenby S, et al. Among authors: de jong pg. Lancet. 2023 Jul 1;402(10395):54-61. doi: 10.1016/S0140-6736(23)00693-1. Epub 2023 Jun 1. Lancet. 2023. PMID: 37271152 Clinical Trial.
ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.
de Jong PG, Quenby S, Bloemenkamp KW, Braams-Lisman BA, de Bruin JP, Coomarasamy A, David M, DeSancho MT, van der Heijden OW, Hoek A, Hutten BA, Jochmans K, Koks CA, Kuchenbecker WK, Mol BW, Torrance HL, Scheepers HC, Stephenson MD, Verhoeve HR, Visser J, de Vries JI, Goddijn M, Middeldorp S. de Jong PG, et al. Among authors: de bruin jp, de vries ji. Trials. 2015 May 7;16:208. doi: 10.1186/s13063-015-0719-9. Trials. 2015. PMID: 25947329 Free PMC article. Clinical Trial.
Progress of the ALIFE2 study: A dynamic road towards more evidence.
Hamulyák EN, de Jong PG, Scheres LJJ, Ewington LJ, Middeldorp S, Quenby S, Goddijn M. Hamulyák EN, et al. Among authors: de jong pg. Thromb Res. 2020 Jun;190:39-44. doi: 10.1016/j.thromres.2020.03.015. Epub 2020 Mar 18. Thromb Res. 2020. PMID: 32298839 Free article. Review.
Antithrombotic therapy for pregnancy loss.
de Jong PG, Goddijn M, Middeldorp S. de Jong PG, et al. Hum Reprod Update. 2013 Nov-Dec;19(6):656-73. doi: 10.1093/humupd/dmt019. Epub 2013 Jun 13. Hum Reprod Update. 2013. PMID: 23766357 Review.
Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.
Rodger MA, Gris JC, de Vries JIP, Martinelli I, Rey É, Schleussner E, Middeldorp S, Kaaja R, Langlois NJ, Ramsay T, Mallick R, Bates SM, Abheiden CNH, Perna A, Petroff D, de Jong P, van Hoorn ME, Bezemer PD, Mayhew AD; Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group. Rodger MA, et al. Lancet. 2016 Nov 26;388(10060):2629-2641. doi: 10.1016/S0140-6736(16)31139-4. Epub 2016 Oct 6. Lancet. 2016. PMID: 27720497
Imaging for the exclusion of pulmonary embolism in pregnancy.
van Mens TE, Scheres LJ, de Jong PG, Leeflang MM, Nijkeuter M, Middeldorp S. van Mens TE, et al. Among authors: de jong pg. Cochrane Database Syst Rev. 2017 Jan 26;1(1):CD011053. doi: 10.1002/14651858.CD011053.pub2. Cochrane Database Syst Rev. 2017. PMID: 28124411 Free PMC article. Review.
78 results